BPG is committed to discovery and dissemination of knowledge
Opinion Review
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120789
Published online Jun 27, 2026. doi: 10.4254/wjh.120789
Table 1 Therapeutic potential of kaempferol across various experimental models
Ref.
Model
Route
Findings
Baghaei et al[42], 2022HepG2 cellsEnhanced fatty acid oxidation and reduced lipogenesis
BinMowyna and AlFaris[44], 2021Mice OrallyAnti-diabetic effect via activating the AMPK pathway
Park et al[43], 2025RatsOrally (250 mg/kg BW)Decreased the acetylation of all SIRT1 targets, including PARP1, NF-κB, FOXO-1 and p53 that mediate antioxidant, anti-inflammatory and anti-apoptotic effects
Aodah et al[45], 2024HepG2 C8 cellsUpregulation of antioxidant response elements (ARE)-mediated antioxidative enzymes, such as heme oxygenase, catalase and superoxide dismutases under the control of Nrf2 signaling pathways
Saw et al[46], 2014MiceOrally (25, 50, 100 mg/kg BW)Reduced CCl4-induced liver damage via restoring gut microbiota diversity, increasing beneficial genera (e.g., Lactobacillus), and activating Nrf2 signaling
Alkandahri et al[52], 2023MiceIntraperitoneal (2.5, 5, 10, 20, 40 mg/kg BW)Increased the expression of Grp78, decreased the expression of CHOP, and protected hepatocytes from ER stress-induced apoptosis
Shi et al[58], 2025Rats50 mg/kg BWkaempferol-loaded nanoparticles (KFP-NPs) improved the antioxidant defense, evidenced by increased levels of SOD, GPx, and Nrf2 in SD rats
Qu et al[60], 2025Raw 264.7 macrophage24 μmol/L drugsKaempferol-loaded fibroin nanoparticles downregulate the expression of TNF-α and eliminate the intracellular reactive oxygen in raw macrophages


Write to the Help Desk